📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
Latest filing: 2026-08-14 18:47
364 analysed today
364
Today
136,372
All-time analysed
40,432
Positive
6,316
Negative
81,696
Neutral
7,860
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
28 announcements match the current filters (relevance ≥ 5).
Q1 FY27 Call Transcript: EBITDA Margin Falls 820 bps to 8.4% on Raw Material Inflation
Jyothy Labs released the transcript of its Q1 FY27 earnings call, highlighting significant near-term margin pressure caused by crude-linked input cost inflation. Excluding the discontinued Pril business, revenue grew 8.1% in value and 5.3% in volume YoY, led by Fabric Care (+14% value, +10% volume). However, gross margin contracted 950 bps YoY to 38.5% and EBITDA margin dropped 820 bps YoY to 8.4% despite cutting A&P spending from 10.8% to 6.5% of revenue. Management expects H2 FY27 margins to improve progressively and reported a healthy net cash balance of approximately ₹850 crore.
Confidence: HIGH
What changedFiling of the official Q1 FY27 earnings conference call transcript, detailing segment reclassification (Fabric Care, Home Care, Personal Care) and the impact of the Pril divestment effective May 31, 2026.
Why it mattersHigh raw material inflation in crude-linked inputs severely compressed operating profitability (EBITDA margin halved to 8.4%), showing temporary limits to pricing power in core categories amid intense competition.
EBITDA Margin: 8.4%Gross Margin Drop: 950 bpsRevenue Growth (ex-Pril, Value): 8.1%Net Cash Balance: INR850 croresNet Cash to Market Cap: ~11.6%
📅 Short termMargin recovery will be delayed as high-cost raw material inventory continues to flow through Q2 FY27, with relief expected only from Q3 (October onwards).
📈 Long termVolume growth in Fabric Care remains robust (10%), and the ₹850 crore cash balance provides a strong buffer while the company scales higher-margin Personal Care and new launches.
⚠ Risk flags
- Crude and commodity inflation squeezing gross margins
- Competitive pricing pressure limiting pass-through ability
- Pril brand exit creating near-term drag on Home Care segment scale
Key Highlights
Revenue growth (ex-Pril and FA) stood at 8.1% value and 5.3% volume YoY in Q1 FY27
EBITDA margin compressed by 820 bps YoY to 8.4%, flowing from a 950 bps drop in gross margin to 38.5%
Advertising & promotion (A&P) spend was trimmed to 6.5% of revenue versus 10.8% in Q1 FY26
Fabric Care segment outperformed with >14% value and 10% volume growth YoY
Net free cash balance reported at approximately ₹850 crore
👀 What to Watch
Track input cost trends (crude-linked derivatives and soap noodles) and management's margin recovery trajectory heading into H2 FY27.
50.8% PAT Drop in Q1 FY27 as Gross Margins Contract to 38.5%
Jyothy Labs reported a weak Q1 FY27 with PAT declining 50.8% YoY to ₹47.6 Cr, primarily driven by a sharp contraction in gross margins from 48% to 38.5%. While headline revenue grew 3% to ₹773 Cr, underlying growth (excluding divested brands Pril & Fa) was healthier at 8.1% value and 5.3% volume. Operating EBITDA fell 47.9% to ₹64.7 Cr as raw material inflation and packaging costs pressured the bottom line. The company has restructured its reporting into three segments: Fabric Care, Home Care, and Personal Care.
Confidence: HIGH
What changedA significant deterioration in profitability despite stable volume growth, alongside a restructuring of business segments into three core pillars.
Why it mattersThe sharp margin drop indicates high sensitivity to input costs and limited immediate pricing power in a competitive FMCG environment, significantly impacting short-term earnings quality.
Revenue Growth (Ex-Pril/Fa): 8.1%EBITDA Margin: 8.4%PAT Decline: 50.8%Gross Margin: 38.5%Direct Reach: 1.4 Mn Outlets
📅 Short termNegative sentiment is expected due to the nearly 50% drop in EBITDA and PAT, reflecting severe margin pressure that may persist until input costs stabilize.
📈 Long termThe company is focusing on volume-led growth and expanding into new formats like liquids and incense sticks, but structural margin recovery is the key long-term monitorable.
⚠ Risk flags
- Raw material inflation
- Packaging cost volatility
- Intense competition from MNCs
- Significant margin contraction
Key Highlights
Net Profit (PAT) declined by 50.8% YoY to ₹47.6 Cr for the quarter ended June 30, 2026
Gross margins contracted by 950 basis points to 38.5% due to raw material and packaging cost inflation
Excluding discontinued brands Pril & Fa, value growth stood at 8.1% with volume growth at 5.3%
Fabric Care segment led growth with a 14.1% YoY increase to ₹399 Cr
Operating EBITDA margin halved to 8.4% from 16.5% in the previous year's corresponding quarter
👀 What to Watch
Monitor the trajectory of crude-linked raw material prices and the company's ability to pass on costs through pricing. Watch the scaling of new launches like Maxo Agarbatti and Exo Liquid to see if they can improve the margin profile in upcoming quarters.
₹773 Cr Revenue in Q1 FY27; EBITDA Margins Contract to 8.4% Amid Commodity Inflation
Jyothy Labs reported a modest 3.0% YoY revenue growth to ₹773 crore for Q1 FY27, though its core portfolio (excluding Pril and Fa) showed stronger resilience with 8.1% value growth. Profitability was significantly impacted by elevated crude-linked input costs and commodity inflation, causing Operating EBITDA margins to drop to 8.4%, well below the TTM average of 16.1%. PAT for the quarter stood at ₹47.6 crore, representing approximately 14% of the TTM PAT. While the Fabric Care segment performed well with 10.2% volume growth, urban demand remains subdued.
Confidence: HIGH
What changedThe company faced significant commodity headwinds and a transition in its Pril/Fa portfolio, leading to a sharp decline in operating margins despite steady volume growth in its core Fabric Care business.
Why it mattersThe margin contraction to 8.4% (vs 16.1% TTM) indicates that input cost pressures are currently outpacing the company's pricing power and cost-efficiency measures, posing a short-term risk to earnings growth.
Revenue (Q1 FY27): ₹773 croreOperating EBITDA Margin: 8.4%PAT (Q1 FY27): ₹47.6 croreFabric Care Volume Growth: 10.2%Q1 Revenue vs TTM Revenue: 26.7%
📅 Short termThe stock may face pressure in the short term due to the significant margin miss compared to historical performance and TTM averages.
📈 Long termStructural growth remains tied to rural expansion and the success of new launches like Exo Dishwash Liquid and Maxo Incense Sticks; however, margin recovery is essential for long-term value creation.
⚠ Risk flags
- Significant margin contraction
- Crude-linked input cost volatility
- Subdued urban consumption
Key Highlights
Revenue reached ₹773 crore, a 3.0% value growth compared to the same quarter last year.
Core portfolio (excluding Pril and Fa) delivered 5.3% volume growth and 8.1% value growth.
Operating EBITDA margin contracted sharply to 8.4% from historical levels due to input cost volatility.
Fabric Care segment led growth with 14.1% value growth and 10.2% volume growth.
Profit After Tax (PAT) for the quarter was reported at ₹47.6 crore.
👀 What to Watch
Investors should monitor the trend of crude-linked raw material prices and the company's ability to implement 'calibrated pricing actions' to recover margins. The key metric to watch in the next quarter is whether EBITDA margins stabilize back toward the 15-16% range.
50.8% PAT drop in Q1 FY27 as EBITDA margins contract to 8.4% on input cost inflation
Jyothy Labs reported a significant decline in profitability for Q1 FY27, with PAT falling 50.8% YoY to ₹47.6 Cr. While revenue grew 3% to ₹773 Cr, Operating EBITDA margins collapsed from 16.5% to 8.4% due to a 950 bps drop in gross margins caused by abnormal raw material inflation. Excluding the impact of the Pril and Fa brands (discontinued after May 2026), underlying value growth was healthier at 8.1% with volume growth of 5.3%. The company has restructured its reporting into three segments: Fabric Care, Home Care, and Personal Care.
Confidence: HIGH
What changedThe company experienced a sharp contraction in profitability despite steady volume growth, alongside a transition in its brand portfolio as Pril and Fa sales were only included until May 31, 2026.
Why it mattersThe halving of PAT and significant margin erosion highlight the company's current vulnerability to input cost volatility and competitive pricing pressures in the FMCG sector.
Q1 FY27 Revenue: ₹773 CrPAT Growth (YoY): -50.8%EBITDA Margin: 8.4%Gross Margin: 38.5%A&P Spend: ₹50.6 CrRevenue vs TTM Revenue: ~26.7%
📅 Short termThe stock may face downward pressure in the near term as the market reacts to the substantial margin miss and profit decline.
📈 Long termLong-term recovery depends on the company's ability to restore EBITDA margins to the 16-17% range through premiumization and operational efficiencies, while maintaining its 5%+ volume growth trajectory.
⚠ Risk flags
- Abnormal raw material and packaging cost inflation
- Intense competitive intensity through promotions and price-offs
- Revenue loss from discontinued/divested brands (Pril & Fa)
Key Highlights
PAT declined by 50.8% YoY to ₹47.6 Cr from ₹96.8 Cr in the same quarter last year.
Operating EBITDA margin compressed to 8.4% from 16.5% YoY, driven by a 9.5% hit to gross margins.
Gross margins fell to 38.5% compared to 48.0% in Q1 FY26 due to crude-linked input inflation.
Fabric Care segment grew 14.1% YoY to ₹399 Cr, while Home Care (including Pril) declined 9.0%.
Direct reach expanded to 1.4 million outlets with total availability across 4 million outlets.
👀 What to Watch
Investors should monitor the trajectory of raw material prices and the company's ability to implement price hikes to recover margins. The key execution metric will be the successful scaling of new launches like Maxo Agarbatti and Exo Dishwash Liquid to fill the revenue gap left by the Pril and Fa brands.
₹47.64 Cr Q1 Net Profit: Jyothy Labs Profit Drops 50.8% YoY Amid Rising Material Costs
Jyothy Labs reported a modest 2.95% YoY revenue growth to ₹773.40 Cr for Q1 FY27, but net profit plummeted 50.8% to ₹47.64 Cr from ₹96.79 Cr in the year-ago period. The primary headwind was a 49.9% surge in material costs, which reached ₹530.33 Cr, significantly compressing margins. While the Fabric Care segment showed resilience with 14.1% revenue growth, the Home Care segment's profitability crashed by 82.4% YoY. Basic EPS for the quarter halved to ₹1.30 compared to ₹2.64 in Q1 FY26.
Confidence: HIGH
What changedJyothy Labs faced a significant margin squeeze in Q1 FY27, with material costs rising much faster than revenue, leading to a sharp decline in bottom-line performance.
Why it mattersThe results indicate a struggle to pass on input cost increases to consumers, particularly in the Home Care segment, which could impact the company's TTM profitability and valuation multiples.
Q1 Revenue: ₹773.40 CrQ1 Net Profit: ₹47.64 CrMaterial Cost YoY Increase: 49.9%Fabric Care Revenue Growth: 14.1%Home Care PBIT Decline: 82.4%Q1 Revenue vs TTM Revenue: 26.7%
📅 Short termThe stock is likely to face downward pressure in the short term as the market reacts to the significant profit miss and margin contraction.
📈 Long termLong-term recovery depends on the stabilization of raw material prices and the company's ability to leverage its volume-led expansion strategy in rural markets to regain operating leverage.
⚠ Risk flags
- Severe raw material cost inflation
- Sharp margin contraction in Home Care segment
- Limited pricing power in a competitive FMCG environment
Key Highlights
Net Profit fell 50.8% YoY to ₹47.64 Cr from ₹96.79 Cr in Q1 FY26.
Cost of materials consumed surged by 49.9% to ₹530.33 Cr, representing 68.6% of revenue.
Fabric Care revenue grew 14.1% YoY to ₹398.89 Cr, remaining the largest segment.
Home Care segment PBIT collapsed to ₹8.14 Cr from ₹46.27 Cr in the corresponding previous quarter.
Total expenses rose 12.9% YoY to ₹726.07 Cr despite only 2.95% revenue growth.
👀 What to Watch
Investors should monitor management's commentary regarding raw material price volatility and their ability to implement price hikes to restore margins. The sharp decline in Home Care profitability is a key area of concern for the next few quarters.
Jyothy Labs 35th AGM: Rs 3.50 Dividend Declared; Pril & Fa Licenses to End May 2026
Jyothy Labs concluded its 35th AGM, confirming a final dividend of Rs 3.50 per share for FY 2025-26. A significant strategic update involves the non-renewal of Henkel's Pril and Fa brand licenses after May 31, 2026, with the company pivoting to its owned brand 'Exo' for dishwash formats. Operationally, the company added approximately 100,000 outlets and achieved 26% growth in modern trade and e-commerce channels. Sustainability efforts were highlighted with Zero Liquid Discharge implemented at 12 plants.
Confidence: HIGH
What changedThe company officially concluded its 35th AGM, ratifying the FY26 dividend and re-appointing directors while providing a firm end-date for licensed brands.
Why it mattersConfirms the payout to shareholders and signals a strategic shift toward owned brands to replace licensed revenue streams, which may impact long-term margins.
Dividend per share: Rs 3.50Modern Trade/E-comm growth: 26%Outlets added: 1,00,000Shareholder attendance: 47.64%Plants with Zero Liquid Discharge: 12
📅 Short termNeutral; the dividend payout and AGM proceedings are expected. The market will look for the record date and payment timeline.
📈 Long termThe shift from licensed brands (Pril/Fa) to owned brands (Exo) is a structural change that could impact margins and brand equity in the dishwash segment over the next 2-3 years.
⚠ Risk flags
- Loss of licensed brands (Pril, Fa) by May 2026
- Volatile input costs
- Intense competition from MNCs in the personal care segment
Key Highlights
Final dividend of Rs 3.50 per equity share (350% of face value) declared for FY 2025-26
Henkel AG & Co. KGaA license for Pril and Fa brands will not be renewed beyond May 31, 2026
Modern Trade, e-commerce, and quick commerce channels grew by 26% during the year
Approximately 1,00,000 retail outlets were added to the distribution network during the year
Zero Liquid Discharge facilities implemented at 12 manufacturing plants to date
👀 What to Watch
Monitor the transition of the dishwash portfolio from the licensed 'Pril' brand to the owned 'Exo' brand and its impact on market share post-May 2026.
Jyothy Labs Loses Pril License (7-8% Revenue Impact); Initiates Arbitration Against Henkel
Jyothy Labs has ceased manufacturing and distributing Henkel-owned brands 'Pril' and 'Fa' effective June 1, 2026, after Henkel declined to renew the 15-year license agreement. The 'Pril' brand is a significant contributor, accounting for approximately 7-8% of the company's total revenue (est. ₹225-240 crores). The company has initiated arbitration at the Singapore International Arbitration Center (SIAC) to dispute the exit framework and seek compensation for the goodwill created over the license period. Management expects FY 2027 to be a transition year with near-term margin softness as they pivot to scaling their in-house brand 'Exo' in the dishwash liquid segment.
Key Highlights
Henkel terminated the brand license for Pril and Fa effective June 1, 2026, after 15 years of partnership.
Pril brand accounts for approximately 7% to 8% of Jyothy Labs' total annual revenue.
Company has initiated legal arbitration at SIAC regarding contractual rights and valuation of business momentum/goodwill.
Management expects FY 2027 to be a transition year with anticipated pressure on revenue mix and operating margins.
Perpetual licenses for Henko and Mr. White brands remain unaffected and carry no royalty obligations.
👀 What to Watch
Investors should brace for short-term revenue and margin volatility in FY 2027 and closely monitor the company's ability to migrate Pril's consumer base to the 'Exo' brand. The outcome of the SIAC arbitration remains a key monitorable for potential one-time cash inflows from goodwill valuation.
Jyothy Labs Announces ₹3.50 Final Dividend and 35th AGM Scheduled for July 14, 2026
Jyothy Labs Limited has convened its 35th Annual General Meeting (AGM) for July 14, 2026, to adopt the FY 2025-26 financial statements. The Board has recommended a final dividend of ₹3.50 per equity share of ₹1 face value, with the record date set for June 29, 2026. Key agenda items include the re-appointment of Mr. Aditya Sapru as an Independent Director for a second five-year term and approval for director commissions up to 1% of net profits.
Key Highlights
Proposed final dividend of ₹3.50 per equity share for the financial year 2025-26.
Record date for dividend eligibility is fixed as Monday, June 29, 2026.
Re-appointment of Mr. Aditya Sapru as Independent Director for a second 5-year term from 2027 to 2032.
Approval sought for annual commission to non-executive directors not exceeding 1% of net profits.
The 35th AGM will be conducted virtually via Video Conferencing on July 14, 2026.
👀 What to Watch
Investors seeking the ₹3.50 dividend must ensure they hold the stock before the record date of June 29, 2026. Shareholders should also review the proposed remuneration and director re-appointments during the virtual AGM.
Jyothy Labs Announces ₹3.50 Final Dividend; 35th AGM Scheduled for July 14, 2026
Jyothy Labs Limited has convened its 35th Annual General Meeting for July 14, 2026, to approve a final dividend of ₹3.50 per equity share for FY 2025-26. The record date for dividend eligibility is set for June 29, 2026. Key agenda items include the re-appointment of Mr. Aditya Sapru as an Independent Director for a second five-year term and the approval of commission-based remuneration for non-executive directors capped at 1% of net profits.
Key Highlights
Proposed final dividend of ₹3.50 per equity share of face value ₹1 for the financial year 2025-26.
Record date for determining dividend entitlement is fixed as Monday, June 29, 2026.
Re-appointment of Mr. Aditya Sapru as Independent Director for a second term from 2027 to 2032.
Proposed commission to non-executive directors not to exceed 1% of the company's annual net profits.
The 35th AGM will be conducted virtually via Video Conferencing on July 14, 2026, at 11:30 A.M.
👀 What to Watch
Investors interested in the ₹3.50 dividend should ensure they hold the stock prior to the record date of June 29, 2026. The re-appointment of directors suggests management stability, which is a positive sign for long-term shareholders.
Jyothy Labs Shares Recording of Call on PRIL and Fa Brand License Updates
Jyothy Labs Limited has released the audio recording of its analyst and investor conference call held on June 18, 2026. The primary focus of the call was to provide updates regarding the licensing of the 'PRIL' and 'Fa' brands. This disclosure is in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Investors can access the recording through the link provided on the company's official website.
Key Highlights
Conference call conducted on June 18, 2026, at 17:00 hours IST specifically for brand license updates.
Discussion centered on the 'PRIL' and 'Fa' brand licenses, which are key components of the company's product portfolio.
The recording has been made publicly available via a direct link on the Jyothy Labs website for transparency.
The filing follows a prior intimation regarding the call sent to exchanges on June 15, 2026.
👀 What to Watch
Investors should listen to the recording to understand any changes in the licensing terms or duration for PRIL and Fa, as these could impact the company's future revenue and royalty expenses.
Jyothy Labs to Hold Investor Call on June 18 for PRIL and Fa Brand License Update
Jyothy Labs Limited has scheduled a conference call for analysts and investors on Thursday, June 18, 2026, at 17:00 IST. The call is specifically dedicated to providing an update on the 'PRIL' and 'Fa' brand licenses, which are key assets in the company's portfolio. This disclosure is made in compliance with Regulation 30 of the SEBI (LODR) Regulations, 2015. The call is being coordinated by ICICI Securities and includes international toll-free access for Singapore, Hong Kong, UK, and USA.
Key Highlights
Conference call scheduled for June 18, 2026, at 5:00 PM IST to discuss brand license updates.
The discussion will focus specifically on the status and updates regarding the 'PRIL' and 'Fa' brands.
Universal access numbers for the call are +91 22 6280 1144 and +91 22 7115 8045.
The event is organized in coordination with ICICI Securities' equity and research heads.
Information is disseminated under SEBI Listing Obligations and Disclosure Requirements.
👀 What to Watch
Investors should attend or review the transcript of the June 18 call to understand any changes in licensing terms, royalty structures, or duration for the PRIL and Fa brands, as these could significantly impact future margins and market share in the dishwashing and personal care segments.
Jyothy Labs to Pursue Legal Action Against Henkel Over Pril and Fa Brand License Exit
Jyothy Labs Limited has decided to initiate legal proceedings against Henkel AG & Co. KGaA following the non-renewal of license agreements for the 'Pril' and 'Fa' brands. The company aims to assert its contractual rights regarding the exit and transition mechanisms stipulated in the agreements dating back to May 31, 2011. This decision follows a Board meeting held on June 15, 2026, where the company evaluated all options to protect its interests after Henkel's initial non-renewal notice on May 9, 2026.
Key Highlights
Jyothy Labs is pursuing legal remedies to assert contractual rights on the exit and transition mechanism for Pril and Fa brands.
The dispute involves License and Technology License Agreements originally executed on May 31, 2011.
The decision follows Henkel AG & Co. KGaA's communication regarding the non-renewal of these key brand licenses.
The Board of Directors met on June 15, 2026, to formally approve the pursuit of legal remedies.
Pril and Fa are significant brands in Jyothy Labs' portfolio, originally acquired through the Henkel India amalgamation.
👀 What to Watch
Investors should closely monitor the legal developments as 'Pril' is a major brand in the dishwash segment; any unfavorable outcome or abrupt transition could impact near-term revenue and market share.
Jyothy Labs to Pursue Legal Action Against Henkel Over Pril and Fa Brand License Non-Renewal
Jyothy Labs has decided to initiate legal proceedings against Henkel AG & Co. KGaA following the non-renewal of license agreements for the Pril and Fa brands. The company is asserting its contractual rights regarding the exit and transition mechanism under the original agreements executed on May 31, 2011. This decision follows a board meeting held on June 15, 2026, after evaluating all available options to protect its interests. The loss of these brands represents a significant change to the company's product portfolio and revenue stream.
Key Highlights
Board approved pursuing legal remedies against Henkel AG & Co. KGaA regarding brand exit mechanisms.
Dispute involves the non-renewal of License and Technology License Agreements for Pril and Fa brands.
The original agreements were executed on May 31, 2011, following the acquisition of Henkel India.
Company aims to assert contractual rights on the transition mechanism to mitigate the impact of the license termination.
This follows a previous notification on May 9, 2026, regarding the non-renewal of these key brands.
👀 What to Watch
Investors should exercise caution as the loss of established brands like Pril and Fa may impact revenue and market share; monitor legal developments and management's strategy to replace these brands.
Jyothy Labs Recommends ₹3.50 Final Dividend; Issues TDS Guidelines for FY 2025-26
Jyothy Labs has recommended a final dividend of ₹3.50 per equity share (350% of face value) for the financial year 2025-26. The company has issued a detailed communication to shareholders regarding the Tax Deduction at Source (TDS) process, which varies based on residency and documentation. Resident individuals can avoid TDS if their total dividend does not exceed ₹10,000, provided their PAN is updated. Shareholders must submit necessary tax exemption forms and documents by the deadline of June 25, 2026.
Key Highlights
Recommended a final dividend of ₹3.50 per equity share of face value ₹1 (350%) for FY 2025-26.
Standard TDS rate of 10% for resident shareholders with valid PAN; 20% for those without PAN or linked Aadhaar.
Exemption from TDS for resident individuals if total dividend income from the company is ₹10,000 or less.
Non-resident shareholders can opt for Tax Treaty rates (DTAA) by submitting TRC and Form 10F.
Deadline for submission of all tax-related documents is June 25, 2026.
👀 What to Watch
Shareholders should verify that their PAN and bank details are correctly updated with their Depository Participant or RTA and submit relevant tax forms by June 25 to ensure correct tax withholding.
Jyothy Labs to Lose Pril and Fa Brand Licenses as Henkel Declines Renewal Beyond May 2026
Jyothy Labs has announced that its long-standing license agreements with Henkel AG & Co. KGaA for the 'Pril' and 'Fa' brands will not be renewed beyond May 31, 2026. These agreements, originally signed in May 2011, covered the manufacturing, distribution, and marketing of these brands in India. Despite negotiations, the company confirmed that no further possibility for renewal exists. Jyothy Labs is now evaluating the financial impact and the business transfer mechanism outlined in the original contract.
Key Highlights
License for 'Pril' and 'Fa' brands to expire on May 31, 2026, ending a 15-year partnership.
Henkel AG & Co. KGaA has officially decided not to renew the manufacturing and distribution rights.
The 2011 agreements include pre-defined clauses for business valuation and transfer in case of discontinuation.
Management is currently assessing the total financial impact of losing these key brands from their portfolio.
👀 What to Watch
Investors should exercise caution as Pril is a significant brand in the company's dishwash segment; monitor the valuation the company receives during the business transfer process.
Jyothy Labs to End 15-Year PRIL and Fa Brand Licenses with Henkel by May 2026
Jyothy Labs has announced that its licensing agreement with Henkel for the 'PRIL' and 'Fa' brands will expire on May 31, 2026, ending a 15-year partnership. While PRIL is a significant anchor in the dishwash liquid segment, the company plans to transition this business to its owned brand 'Exo' to maintain market share. Management expects potential near-term impacts on revenue mix and margins but highlights that brands like Henko and Mr. White remain under perpetual license with no royalties. A contractual exit process is underway, which includes determination of consideration for the business transfer and goodwill created.
Key Highlights
License for 'PRIL' and 'Fa' brands will not be renewed beyond May 31, 2026, after a 15-year term.
Company to scale up owned brand 'Exo' (in portfolio since 2005-06) to replace PRIL in the dishwash liquid category.
Mr. White and Henko brands are unaffected as they are held under perpetual license with zero royalty obligations.
Contractual exit mechanism includes a 'Business Transfer' and determination of consideration for goodwill created.
Management warns of potential near-term pressure on revenue and margins during the transition phase.
👀 What to Watch
Investors should closely monitor the company's ability to migrate PRIL's customer base to the Exo brand and the final compensation received from Henkel for the business transfer. The transition period may lead to short-term volatility in the stock as the market evaluates the impact on the dishwash segment's profitability.
Jyothy Labs to Lose Pril and Fa Brand Licenses as Henkel Declines Renewal Beyond May 2026
Jyothy Labs has announced that Henkel AG & Co. KGaA will not renew the license and technology agreements for the Pril and Fa brands beyond May 31, 2026. These agreements, which have been in place since May 2011, allowed Jyothy Labs to manufacture, market, and distribute these brands in India. Despite attempts to negotiate a renewal, the company has confirmed that no further extension is possible. The company is now initiating the business valuation and transfer mechanism process as per the original agreement terms.
Key Highlights
License for Pril and Fa brands will terminate on May 31, 2026, ending a 15-year partnership.
Henkel AG & Co. KGaA has officially declined renewal after discussions for various options failed.
The agreement includes specific provisions for business valuation and transfer mechanisms upon discontinuation.
Jyothy Labs is currently evaluating the financial impact of losing these brands from its portfolio.
👀 What to Watch
Investors should monitor future disclosures to understand the exact revenue and profit contribution of the Pril brand to Jyothy Labs. The loss of a major brand like Pril may lead to a de-rating or downward revision of growth estimates in the dishwash segment.
Jyothy Labs Q4 FY26: Revenue Up 7.7%, Fabric Care Volumes Surge 17.8% Amid Margin Pressure
Jyothy Labs reported a 7.7% revenue growth in Q4 FY26, driven by a robust 17.8% volume growth in the Fabric Care segment. However, EBITDA margins contracted by 330 basis points to 13.5% due to rising crude-linked input costs and competitive pricing in the Dishwash category. The company successfully reduced losses in the Household Insecticides segment to INR 5 crores for the year, down from INR 25 crores. With a strong cash reserve of INR 1,000 crores and a debt-free balance sheet, the board has recommended a dividend of INR 3.5 per share.
Key Highlights
Q4 revenue grew 7.7% YoY to INR 717 crores, while full-year FY26 revenue reached INR 2,944 crores.
Fabric Care segment delivered exceptional performance with 14.4% value growth and 17.8% volume growth in Q4.
EBITDA margins for Q4 declined to 13.5% from 16.8% YoY, impacted by a 400 bps drop in gross margins.
Household Insecticides losses narrowed significantly from INR 25 crores to INR 5 crores for the full year.
Maintained a strong liquidity position with INR 1,000 crores in cash and declared a dividend of INR 3.5 per share.
👀 What to Watch
Investors should monitor the impact of recent price hikes on volume growth and the company's ability to manage crude-linked inflation. The stock remains a solid play on rural recovery and premiumization in the liquid detergent space.
Jyothy Labs FY26 Net Profit Dips 10.2% to ₹333 Cr; Recommends ₹3.50 Final Dividend
Jyothy Labs reported a 3.5% year-on-year growth in annual revenue to ₹2,944.29 crore for FY26, while net profit declined by 10.2% to ₹333.19 crore. For the fourth quarter, revenue increased by 7.7% to ₹717.41 crore, but net profit fell to ₹67.52 crore from ₹77 crore in the previous year's quarter. The Board has proposed a final dividend of ₹3.50 per share, representing a 350% payout on face value. The record date for the dividend is June 29, 2026, with payment expected after the AGM on July 14, 2026.
Key Highlights
FY26 Revenue from operations grew 3.5% YoY to ₹2,94,429 Lakhs.
Full-year Net Profit declined 10.2% to ₹33,319 Lakhs from ₹37,117 Lakhs in FY25.
Recommended a final dividend of ₹3.50 per equity share for the financial year 2025-26.
Q4 FY26 Revenue rose 7.7% YoY to ₹71,741 Lakhs, though Q4 profit fell 12.3% YoY.
Dividend record date set for June 29, 2026, with the AGM scheduled for July 14, 2026.
👀 What to Watch
The decline in profitability despite revenue growth suggests margin pressure from input costs; investors should monitor management's strategy for margin recovery. The steady dividend payout remains a positive for long-term income-focused investors.
Jyothy Labs FY26 Revenue Up 3.5% to ₹2,944 Cr; PAT Declines 10% Amid Margin Pressure
Jyothy Labs reported a modest 3.5% revenue growth for FY26, reaching ₹2,944 crores, while Q4 revenue grew 7.7% supported by a robust 10.8% volume growth. However, profitability was significantly impacted by rising input costs, with FY26 PAT declining 10.2% to ₹333.2 crores and EBITDA margins contracting to 15.3% from 17.6%. The company maintains a strong balance sheet with a cash balance of ₹997 crores and an efficient working capital cycle of 15 days. Management has signaled a strategy of prioritizing volume growth over margins in the near term due to persistent inflation in crude-linked derivatives.
Key Highlights
FY26 Revenue grew 3.5% to ₹2,944 crores with 6% volume growth; Q4 volume growth was higher at 10.8%.
FY26 PAT decreased by 10.2% to ₹333.2 crores, while Q4 PAT fell 12.3% to ₹67.5 crores.
Operating EBITDA margin contracted to 15.3% for FY26 compared to 17.6% in the previous year due to input cost inflation.
Fabric Care and Dishwash segments showed strong Q4 momentum, growing by 14.4% and 20.1% respectively.
Cash and bank balances increased to ₹997 crores, providing significant liquidity for future expansions.
👀 What to Watch
Investors should monitor the company's ability to implement price hikes to offset input cost inflation, as margins are currently under pressure despite healthy volume growth. The strong cash position and market share gains are positive, but near-term earnings may remain volatile until raw material prices stabilize.
